October 17, 2025- Cleveland Clinic has entered into an agreement with DASI Simulations to co-develop the next generation of AI predictive modeling solutions for the treatment of structural heart diseases. Cleveland Clinic also will utilize DASI’s existing technology to support planning and treatment for current TAVR patients at Cleveland Clinic.
Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive procedure to replace a diseased aortic valve with an artificial valve without the need for open-heart surgery. As part of a two-year co-development partnership, DASI and Cleveland Clinic are working to develop innovative AI technology that can assist doctors in real time during heart procedures. By combining Cleveland Clinic’s clinical expertise and extensive data with DASI’s advanced AI models, the goal is to create the world’s first AI-powered “co-pilot” system for catheterization labs.